Abstract To reveal the underlying mechanisms responsible for the regional vulnerability to amyloid-b (Ab) accumulation prior to the development of Alzheimer's disease, we studied distribution of Ab, apolipoprotein E (apoE), synaptic markers, and other molecules involved in Ab metabolism in multiple brain areas of non-demented individuals. Twelve brain regions including neocortical, limbic, and subcortical areas were dissected from brains of non-demented individuals and extracted according to increasing insolubility by a sequential three-step method. The levels of Ab40, Ab42, apoE, APP, APP-CTFb, BACE1, presenilin-1, neprilysin, insulysin, LRP1, LDLR, synaptophysin, PSD95, GFAP, and lactate were determined by ELISAs or enzymatic assays. The regional distribution of apoE showed moderate-to-strong inverse correlation with levels of Ab, especially insoluble Ab40. On the other hand, the regional distributions of synaptic markers, particularly PSD95, showed moderate-to-strong positive correlation with levels of Ab, especially soluble Ab40. The regional correlations between Ab and LRP1, GFAP, or lactate were mild-to-moderate. Moderate-to-strong positive regional correlations were observed between apoE and GFAP or lactate and between PSD95 and LRP1. No significant regional correlations were detected between Ab and APP, APP-CTFb, BACE1, or presenilin-1, those involved in Ab production. There were no significant negative regional correlations between Ab and two major Ab degrading enzymes, neprilysin and insulysin. These regional correlations remained consistent regardless of the degree of Ab accumulation. The regional vulnerability to Ab accumulation may be due to a net balance between two competing processes: (1) synapses involved in promoting the initial Ab accumulation and (2) astrocyte-derived apoE involved in preventing Ab accumulation.
Introduction
Accumulation and aggregation of amyloid-b (Ab) peptides may initiate Alzheimer's disease (AD) pathogenesis (so-called amyloid cascade hypothesis) [4, 26] . Accumulation of Ab is determined by a balance between processes of production and clearance. Ab is produced by proteolytic cleavages of amyloid precursor protein (APP) by b-site cleaving enzyme and subsequent cleavage of b-C-terminal fragments of APP (APP-CTFb) by c-secretase [65] . Neuronal and synaptic activity might be involved in this initial step of Ab metabolism [7, 14] . Upon production, much of Ab is efficiently cleared by Ab degrading enzymes through cellular uptake to lysosomes or brain vasculature. Cellular clearance of Ab by various cell types in brain parenchyma and vasculature is mediated by cell surface Ab-binding receptors and regulated by apolipoprotein E (apoE). Ab can also be cleared through perivascular drainage into the cerebrospinal fluid (CSF) [10, [29] [30] [31] 37] . Over production and/or inefficient clearance of Ab can lead to its accumulation and aggregation and eventual synaptic and neuronal toxicity.
To understand the pathogenesis of AD, it is important to elucidate how Ab accumulates in human brains. Ab deposition appears to begin more than a decade before the onset of AD [4, 26] . Accumulating evidence has shown that risk factors of AD (aging and APOE e4 allele) accelerate accumulation of Ab prior to the development of the disease [47, 53] . Ab deposition typically occurs first in neocortical areas, followed by limbic areas, brainstem regions, including the thalamus and striatum, and finally spreads to the cerebellum [64] . In AD brains, Ab depositions are observed throughout the brain, and especially cortical deposition appears to plateau relatively early in the disease process or prior to the development of AD [8, 26, 27] .
Despite clinical and pathological evidence of regional specificity of Ab depositions, it is not yet clear what factors determine selective vulnerability to Ab accumulation. An emerging hypothesis is that a certain type of neuronal activity regulates region-specific Ab levels, as evidenced by the fact that areas involving default neuronal activity overlap with areas associated with Ab deposition [11, 70] . Regional associations presumably exist between levels of Ab and molecules or markers involved in Ab metabolism; however, the regional distribution of molecules involved in Ab metabolism has not been fully investigated. Here, we provide a post-mortem analysis of regional neuroanatomical distribution of Ab as well as molecules and markers related to Ab metabolism, in brains of non-demented individuals within extracts based upon differential solubility in detergents and chaotropic agents.
Materials and methods

Sample preparation
Post-mortem tissues were obtained through the Mayo Clinic Brain Bank under procedures approved by the Mayo Clinic Institutional Review Board. All subjects had been enrolled in one of two NIH funded studies, Mayo Clinic Alzheimer Disease Research Center (P50 AG016574) or Mayo Clinic Study on Aging (U01 AG006786), and had standardized antemortem clinical and neuropsychological assessments. Brain samples from 21 non-demented individuals were analyzed. Demographic characteristics are shown in Table 1 . Gray matter of 12 brain areas (Table 2) was dissected and kept frozen until extraction. Brain lysates were prepared according to the three-step extraction method described by Shankar et al. [55] with minor modifications. After removal of meninges and blood vessels, 100-200 mg of frozen brain tissue were homogenized in ice-cold TBS containing a protease inhibitor cocktail (PIC; Roche Diagnostics, Indianapolis, IN, USA) by Polytron homogenizer (KINEMATICA, Bohemia, NY,USA). After centrifugation at 100,0009g for 60 min at 4°C, the supernatant was aliquoted and stored at -80°C (referred to as TBS fraction). The residual pellet was rehomogenized in TBS plus 1 % Triton X-100 with PIC, incubated with mild agitation for 1 h at 4°C and centrifuged as above. The resultant supernatant was aliquoted and stored at -80°C (referred to as TBS-TX fraction). The residual pellet was rehomogenized in TBS plus 5 M guanidine hydrochloride, pH 7.6, and incubated with mild agitation for 12-16 h at 22°C. After centrifugation as above, the resultant supernatant (referred to as GuHCl fraction) was diluted with 9 volume of TBS, aliquoted and stored at -80°C.
Quantification of proteins and lactate
Total protein levels were determined by Bradford method (Bio-Rad, Hercules, CA, USA). The levels of Ab1-40 and Ab1-42 were determined by ELISA as previously described [13] using an end-specific monoclonal antibody (13.1.1 for Ab x-40 and 2.1.3 for Ab x-42) and a HRP-conjugated detector antibody (Ab5, human Ab1-16 specific, all antibodies were in-house produced by Mayo Clinic). The levels of apoE were determined by ELISA using two different goat anti-apoE antibodies, as previously described [3] . The levels of APP were determined by ELISA on TBS-TX fraction using a rabbit anti-C-terminus of APP capture antibody (a gift from Dr. Pritam Das) and biotin-conjugated MAB890 detector antibody (R&D, Minneapolis, MN, USA). The recombinant human APP proteins (OriGene, Rockville, MD, USA) were used as standards. The levels of APP-CTFb were determined by ELISA on TBS-TX fraction using an MMSE score of mini-mental state examination, CDR clinical dementia rating scale, NFT neurofibrillary tangle, PMI post-mortem interval above-mentioned rabbit anti-C-terminus of APP capture antibody and biotin-conjugated 82E1 detector antibody (IBL-America, Minneapolis, MN, USA). Synthetic peptides, consisted of 15 a.a. of N-terminus of Ab and 20 a.a. of C-terminus of APP, were used as standards. The levels of insulin degrading enzyme (IDE, or insulysin) were determined by ELISA on TBS fraction using 6H9 capture antibody and biotin-conjugated 6A1 detector antibody (gifts from Dr. Malcolm Leissring), as previously described [16] . The levels of b-site APP-cleaving enzyme 1 (BACE1), N-terminal fragments of presenilin-1, and Neprilysin (NEP) were determined on TBS-TX fraction by commercial ELISA kit (R&D). The levels of glial fibrillary acidic protein (GFAP) were determined by ELISA on TBS fraction using rabbit anti-GFAP capture antibody (US Biological, Swampscott, MA, USA) and biotin-conjugated GA-5 detector antibody (Abcam, Cambridge, MA, USA). GFAP proteins purified from human brain (Millipore, Billerica, MA, USA) were used as standards. The levels of low-density lipoprotein receptor (LDLR) were determined by ELISA on TBS-TX fraction using Irene capture antibody [52] and biotin-conjugated goat anti-LDLR detector antibody (R&D). The recombinant human LDLR proteins (R&D) were used as standards. The levels of LDLR-related protein 1 (LRP1) were determined by ELISA on TBS-TX fraction using 6F9 capture antibody and biotin-conjugated 5A6 detector antibody (Molecular Innovations, Novi, MI, USA). LRP1 proteins purified from human placenta were used as standards. The levels of postsynaptic density 95 (PSD95) were determined by ELISA on TBS fraction using rabbit anti-PSD95 capture antibody (Osenses, Keswick, SA, Australia) and biotin-conjugated mouse anti-PSD95 detector antibody (NeuroMab, Davis, CA, USA). The recombinant human PSD95 proteins (Novus Biologicals, Littleton, CO, USA) were used as standards. The levels of synaptophysin were determined by ELISA on TBS-TX fraction using rabbit anti-synaptophysin antibody (Osenses) and biotin-conjugated mouse anti-synaptophysin antibody (Acris Antibodies, San Diego, CA, USA). The recombinant human synaptophysin proteins (Novus Biologicals) were used as standards. Levels of specific proteins and lactate (with the exception of total protein, Ab and apoE) were determined on one of the three fractions, based on their abundance among these fractions. Specifically, TBS fraction was used to measure levels of cytosolic/secreted proteins and molecules (i.e., IDE, GFAP, PSD95, and lactate); whereas TBS-TX fraction was used to measure levels of membrane proteins (i.e., APP, APP-CTFb, BACE1, presenilin-1, NEP, LDLR, LRP1, and synaptophysin). Colorimetric quantification was performed on a Synergy HT plate reader (BioTek, Winooski, VT, USA) using horseradish peroxidase (HRP)-linked streptavidin (Vector, Burlingame, CA, USA) or Poly-HRP 40 streptavidin (Fitzgerald, Acton, MA, USA) and 3,3 0 ,5,5 0 -tetramethylbenzidine substrate (Sigma, St Louis, MO, USA). Brain lactate levels were determined on TBS fraction using enzymatic lactate assay kit according to the manufacture's instruction (BioVision, Milpitas, CA, USA). Colorimetric quantification was performed on a Synergy HT plate reader.
Data analysis
All measured values were first normalized by total protein levels in the sample. Comparisons of cortical Ab and apoE levels (averaged value of cortical areas) among three fractions were performed by ANOVA followed by paired t test with Holm correction for multiple comparisons (R, version 2.14.1; The R foundation, Vienna, Austria). When comparing regional differences, each measured value normalized by total protein levels was then normalized by the average value within an individual to adjust for the influence of difference between individuals. Comparisons of such normalized values among different brain areas were performed by ANOVA followed by paired t test with Holm correction for multiple comparisons (R). The non-parametric Spearman rank correlation coefficient was used to summarize the degree of correlation between median levels of each protein across 12 brain regions (JMP, version 7; SAS, Cary, NC). The p values of \0.05 were considered significant.
Results
Regional distribution of Ab
We evaluated levels of Ab extracted into three fractions: (1) TBS-soluble pool (TBS fraction), (2) TBS-insoluble but Triton-X soluble pool (TBS-TX fraction), and (3) TBS and Triton-X-insoluble but GuHCl soluble pool (GuHCl fraction). Average Ab40 levels of cortical areas were highest in GuHCl fraction compared to other fractions (Supplementary Fig. 1 ). We observed a trend in differential Ab40 distributions by anatomical region with neocortical areas being the highest, followed by limbic areas and then subcortical areas, though there was not a significant difference between neocortical and limbic areas (Fig. 1a-c) . A mixed model statistical analysis showed significant differences in Ab40 levels among cortical areas as well as between neocortical and limbic areas (see Supplementary Materials and Methods and Supplementary Fig. 2 ). Since we encountered difficulties in measuring Ab42 in TBS and TBS-TX fraction in a pilot study, especially in individuals with low Ab levels, we determined the regional distribution of Ab42 only in GuHCl fraction (Fig. 1d ). The regional distribution of Ab42 in GuHCl fraction strongly correlated with that of Ab40, suggesting the same regional specificity of Ab40 and Ab42 levels ( Supplementary Fig. 3 ). To confirm that such regional distribution trends persist regardless of the degree of Ab accumulation, we firstly, separated individuals into two groups: (1) low levels of cortical Ab and (2) intermediate-to-high levels of cortical Ab (see Supplementary  Materials and Methods and Supplementary Table 1) , and found similar trends of regional distribution of Ab between the two groups (Supplementary Table 2 ). Moreover, we separated individuals on a histochemical basis by the degree of Ab accumulation, namely ''pathological aging'' [17] (Supplementary Table 5 ). Indeed, regional distribution of Ab was well preserved between individuals with/without pathological aging (Supplementary Table 6 ). In addition, we separated individuals on a genetic basis by the presence/ absence of the APOE e4 allele and found similar regional distribution of Ab (Supplementary Table 9 , 10). These results suggest that the regional distribution of Ab is similar among non-demented individuals with different degrees of Ab accumulation or with/without the strong genetic risk factor for AD.
Regional distribution of molecules involved in Ab metabolism
We next determined the regional distribution of molecules linked to Ab metabolism. Cortical apoE levels in GuHCl fraction were around one-tenth of that in TBS or TBS-TX fraction, suggesting that TBS and TBS-TX fractions represent main functional fractions of apoE (data not shown). In these fractions, subcortical areas generally had higher apoE levels than cortical areas. Some limbic areas (AM and EC) had higher apoE levels compared to neocortical areas (Fig. 2a, b) . Frontal-temporal neocortical areas (OF, DF, and IT) and the striatum had higher levels of APP compared with parietal-to-posterior cortical areas (VC, IP, and PC), amygdala, and cerebellum (Fig. 2c) . APP-CTFb levels were lowest in cerebellum among the 12 areas. Some neocortical areas (OF and IT) and the striatum had higher levels of APP-CTFb compared with parietal-to-posterior cortical areas (VC, IP, and PC) and amygdala (Fig. 2d) . Two of the limbic areas (AM and EC) had higher levels of BACE1 (b-secretase) than other areas (Fig. 2e ). Thalamus and hypothalamus had relatively low levels of presenilin-1, the major enzymatic component of c-secretase (Fig. 2f) . NEP levels were much higher in striatum compared to other areas (Fig. 2g) . Although IDE levels in thalamus and cerebellum were variable with some extreme outliers, some cortical areas (DF, IT, IP, and OF) had higher IDE levels (Fig. 2h) . LDLR levels were lowest in the striatum (Fig. 2j) , whereas LRP1 levels were lowest in the thalamus (Fig. 2i) . Two cortical areas (OF and EC) had higher synaptophysin (a presynaptic marker) levels compared to amygdala (Fig. 2k ). Neocortical areas generally had higher PSD95 (a postsynaptic marker) levels compared to subcortical areas. Frontal-to-temporal cortices (DF, OF, and IT) tended to have higher PSD95 levels compared to parietal-to-posterior cortical and limbic areas. Among subcortical areas, we observed higher PSD95 levels in the striatum than in the thalamus and cerebellum (Fig. 2l ). Subcortical areas generally had higher lactate and GFAP (an astrocytic marker) levels compared to cortical areas. GFAP levels were also higher in some of limbic areas (AM and EC) compared to neocortical areas (Fig. 2m, n) .
Regional associations among Ab and molecules involved in Ab metabolism
We then assessed the association between the regional distributions of Ab and these related molecules. To reduce the influence of some particularly extreme outliers, a median value of 21 individuals was used to assign a representative value in each area. Since we did not have a priori assumptions of linear relationship between them, these regional distributions were compared by Spearman rank test. The results of this correlation analysis are summarized in Table 3 . There were several significant regional associations between Ab and apoE, IDE, LRP1, GFAP, lactate, synaptophysin, or PSD95. In particular, the regional distribution of Ab40 in TBS fraction was most strongly associated with PSD95 levels ( Fig. 3a ; r = 0.8951, p \ 0.0001). On the other hand, the regional distribution of Ab40 in GuHCl fraction was most strongly associated with apoE levels in TBS fraction ( Fig. 3c ; r = -0.8741, p = 0.0002). Similarly, the regional distribution of Ab40 in TBS-TX fraction was strongly associated with apoE levels (Fig. 3b) . The regional distribution of Ab42 in GuHCl fraction was also strongly associated with apoE and PSD95 (see Table 3 ). In addition, these strong regional correlations between Ab and PSD95 or apoE persisted even when separating individuals by the degree of biochemically-determined Ab accumulation (Supplementary Table 3 and 4), histochemicallydetermined Ab accumulation (Supplementary Table 7 and 8), or the presence/absence of the APOE e4 allele (Supplementary Table 11 and 12) . On the contrary, no significant positive regional correlations were detected between Ab and APP, APP-CTFb, BACE1, or presenilin-1, those involved in Ab production. Moreover, there were no significant negative regional correlations between Ab and two major Ab degrading enzymes, NEP and IDE, in total 21 nondemented individuals (see Table 3 ). These regional correlations remained consistent regardless of the degree of Ab accumulation or the presence/absence of the APOE e4 allele (see supplementary To investigate potential relationships among molecules related to Ab metabolism, we next assessed whether correlations in regional distribution exist. The results of this correlation analysis are summarized in Table 4 . Although no correlations were observed between the regional distribution of apoE and apoE receptors (LRP1 and LDLR), significant positive correlations were observed between the regional distribution of apoE and GFAP (Fig. 4a) . This supports the notion that astrocytes are the primary cell type in the brain that produces apoE and dictate the regional distribution of apoE [10] . In addition, there was a strong positive correlation between LRP1 and PSD95 regional distribution (Fig. 4b) . These results are consistent with the previous findings that LRP1 interacts with PSD95, and is mostly localized and functions in postsynaptic sites [41] . A negative correlation was observed between lactate and PSD95, whereas a positive correlation was observed between lactate and GFAP (Fig. 4c) . Such data may support the notion that regional distribution of lactate is characterized by astrocytes, a main source of lactate [51] .
Discussion
To study the underlying mechanisms responsible for the regional vulnerability of Ab accumulation, we evaluated the regional relationship between Ab and several molecules related to Ab metabolism in 21 non-demented individuals across 12 brain areas. We used ELISAs to determine the levels of these molecules, as it is difficult to measure them for comparison across multiple brain areas in the large data set by Western blotting, as well as detect Ab (especially in individuals with low Ab accumulation) and some of the molecules related to Ab metabolism by immunohistochemical staining. Taking advantage of a comprehensive set of ELISAs, the regional distribution of Ab and molecules related to Ab metabolism were systematically compared across multiple areas in an unbiased manner. The regional distribution of Ab40 in TBS fraction and in TBS-TX/GuHCl was most strongly associated with levels of PSD95 and apoE, respectively, even when considering interconnecting correlations (Fig. 5) . The regional distribution of Ab42 in GuHCl was also strongly associated with PSD95 and apoE. It is interesting to note that the regional associations of Ab with PSD95 were positive and those of Ab with apoE were negative. Moreover, these strong correlations persisted throughout individuals with low Ab accumulation (a presumably normal phase before Ab accumulation) and with pathological aging (a possible prodromal phase of AD [17, 46] ) (see Supplementary Table 1-8) . These results suggest that PSD95 and apoE are independently related to the mechanisms that govern region-specific Ab accumulation prior to the development of AD. In light of accruing evidence, we propose that regional vulnerability to Ab accumulation depends on a net balance between two competing processes: (1) synapses are involved in promoting the initial event of Ab accumulation and (2) astrocyte-derived apoE is involved in preventing Ab accumulation.
When interpreting the results of our study, there are some caveats to consider. First, this study does not directly address a causal relationship between Ab and related molecules. Therefore, it remains possible that strong regional associations observed in this study might be mediated by other confounding factors, though such strong associations would provide important implications in either case. Second, our rationale to use samples from nondemented elderly individuals in this study is based on: (1) longitudinal amyloid imaging studies indicate that amyloid accumulation in non-demented elderly individuals is a good predictor of AD development in the future [28, 49, 69] , (2) neuropathological and biochemical studies showed extensive similarities between accumulated Ab in AD and pathological aging [17, 46] , and (3) severe neurodegeneration and neuroinflammation observed in AD [45, 71] could make it difficult to study causal relationships between Ab and molecules involved in Ab metabolism. A third consideration is that protein levels determined by ELISAs do not always reflect activity levels as well as functional properties, as several proteins measured in this study, such as BACE1, presenilin-1, NEP, or IDE, undergo post-transcriptional modifications or possibly reside in cellular compartments different than those in the Ab-related pathway [15, 48, 65] . Further experiments considering protein activity and function would complement key findings in this study.
We were careful to consider, and overcome, potential technical limitations associated with this study. First, we analyzed a particular population of non-demented individuals, though these samples were randomly selected based on the antemortem record. These individuals were mostly very elderly and female (see Table 1 ). Of note, after stratification by each one of the following variables: age, sex, PMI, and Braak stage, the resulting regional correlations were consistent with our previous findings (data not shown) suggesting that such potential confounding factors did not affect the regional associations observed in this To overcome this, we also assessed the regional Table 1-8) . Third, in our correlation analysis, the small number of brain regions studied (12 brain areas) might not be enough to detect regional associations. To improve the robustness of the analysis, we used the median value of 21 individuals and non-parametric tests for comparison. Indeed, several reasonable regional associations were obtained, which support this methodology (see Fig. 4 ). As such, strong regional associations observed in this study would have important implications for the regional specificity of Ab levels. Overall, Ab levels tended to be higher in cortical areas when compared with subcortical areas, though there were no significant differences in Ab levels among neocortical areas or between neocortical and limbic areas by paired t test with Holm correction. This result may partially contradict observations made with histological methods and with clinical amyloid imaging methods, which have reported regional heterogeneity of Ab accumulation in cortical areas of aged individuals [8, 11, 64, 70] . However, our results actually imply a difference in Ab levels among cortical areas, especially soluble Ab (in TBS fraction). These statistically significant differences were achieved by a mixed model analysis shrinking extreme outliers (see Supplementary Fig. 1 ). Indeed, these outliers might be compatible with ''considerable inter-individual differences'' described by Braak et al. [8] , which would make it difficult to define the order of Ab accumulation. For example, eight individuals have an extremely outlying (defined as higher than the 75th percentile ? 3 interquartile range for the particular area) Ab42 level (as normalized value) in GuHCl fraction at variable areas, as some of them are apparent in Fig. 1d . The number of such extreme Ab distribution outliers was generally greater than that of other proteins (data not shown). Moreover, the average of cortical Ab40 or Ab42 levels in these 8 individuals was lower than that of the other 13 individuals (data not shown). These results may suggest that individual differences in region-specific Ab accumulation exist especially during the initial phase of Ab accumulation. Although median values were chosen to examine regional correlations with other molecules to reduce the influence of such extreme outliers for the entire analysis, it may be worthwhile to further explore mechanisms underlying the heterogenic nature of region-specific Ab accumulation. Several previous attempts to implicate the involvement of the Ab production factors in Ab regional specificity have not been successful. Such studies examined the regional distribution of APP, presenilin-1, presenilin-2, and BACE1 in human or rodent brains by histochemical or biochemical techniques [5, 20, 50, 62, 66] . As the level of APP-CTFb may better reflect the rate of Ab production more than the level of APP, we determined the regional distribution of APP-CTFb in addition to APP, BACE1, and presenilin-1. Our results support the conclusion of previous studies. However, if regional alteration of c-secretase activity (probably reflected by presenilin-1 level) affects APP-CTFb levels, it is difficult to exclude the involvement of Ab production in the regional specificity of Ab levels by our method of analysis. Further investigations are needed to test this possibility. It is noteworthy that there was a strong positive regional correlation between APP-CTFb and APP (see Table 4 ). This suggests that the regional distribution of APP-CTFb is actually determined by the regional distribution of APP. Also, our results indicate that Ab production rate in striatum is comparable to or slightly higher than that of cortical areas. Such results may have implications for understanding the striatal vulnerability of Ab deposition in familial AD [33, 68] , and further investigation of this topic would require an examination of samples from familial AD cases.
IDE and NEP are major Ab degrading enzymes, the effects of which have been well characterized in vitro and in vivo by several groups. Importantly, manipulation of levels of these enzymes negatively correlated with Ab levels [18, 25, 39, 42, 43] . In our study, the regional distribution of these two major Ab degrading enzymes did not show significant negative correlations with Ab levels. On the contrary, those of IDE were positively correlated with Ab levels. This appeared to be mediated by regional associations between neuronal markers and IDE, which coincide with the notion that IDE mainly resides in neurons [6] . High levels of NEP in striatum are consistent with previous immunohistochemical studies [1] . Therefore, NEP might have region-specific effects for Ab degradation, especially in striatum. However, deletion of NEP raised Ab levels in cortical and striatum at similar rates in rodent brains [25] , which refutes such region-specific regulation of Ab levels by NEP.
Our results imply that apoE affects the region-specific Ab levels by preventing Ab accumulation. Although apoE is intimately involved in Ab metabolism, its effects are still not clear, especially in vivo or in humans. Previous studies using transgenic mouse models have shown that apoE promotes Ab accumulation [24, 32] , while other studies suggest apoE prevents Ab accumulation in brain [29, 37, 56] . Fundamental differences in lipoprotein metabolism between humans and rodents [12, 21] might generate controversies in apoE effects on Ab metabolism. Of note, several studies showed that levels of apoE are increased by a protective APOE allele [22, 23, 44, 54, 60] . Our results may support such dose-dependent, beneficial effects of apoE on Ab accumulation. While it cannot be ruled out that confounding factors mediate strong correlations between apoE and Ab, the opposite notion that Ab accumulation affects apoE distribution is at least unlikely because the strong associations are observed even in individuals with low Ab levels (see Supplemental Table 3 ). Because the regional distribution of GFAP was also strongly associated with Ab as well as apoE (though sometimes apparently weaker compared to the association between Ab and apoE (e.g., correlation with Ab42 in GuHCl, see Table 3 )), astrocytes may be involved in apoE-mediated or non-apoEmediated Ab disaggregation [37] . Therefore, another marker protein that can distinguish astrocyte subtypes [9, 63] might show stronger and consistent association with Ab. In addition, it may be worth comparing regional vulnerability to Ab accumulation among carriers of different APOE allele to elucidate how the risk allele or protective allele is involved in AD pathogenesis. In this study, we failed to detect a difference in the regional distribution of Ab or regional relationship between Ab and molecules related to Ab metabolism in the presence/absence of the APOE e4 allele (see supplementary Table 9-12). However, this result might be affected by the relatively small number of samples examined as well as our analysis of nondemented individuals. Further studies analyzing a larger number of samples, including AD patients, would be helpful to test this hypothesis.
Synapses are an important site for Ab production and accumulation [34, 36, 38, 40, 57, 61] . The strong regional association between PSD95 and Ab levels, especially in TBS fraction, even in individuals with low Ab accumulation, may suggest the involvement of neuronal or synaptic activity in the regional specificity of Ab levels [7, 14] . However, it cannot be ruled out that Ab is preferably accumulating in postsynaptic structures, as previously observed, in which LRP1 might play an important role [19, 34, 36, 41, 61] . There might also exist a cross-talk between apoE-mediated Ab clearance and synaptic accumulation of Ab, as previously reported by Arold et al. and other groups [2, 35] . Recent studies showed that glutamatergic neurons are involved in Ab accumulation or Ab secretion [58, 59, 67] . Along these lines, specific presynaptic markers of this neuronal type, such as vGluT1 or vGluT2, might be useful to further define the mechanisms underlying strong associations between Ab and PSD95 [58] . Therefore, even if neural activity is involved, a deeper understanding of the underlying mechanism is warranted since our study, as well as previous studies [7, 14] , failed to show the contribution of the Ab production pathway. In addition, we observed regional differences in the distribution of lactate in TBS fraction that correlated with GFAP, reflecting the distribution of astrocytes. Other makers are needed to further prove the involvement of neural activity in regional specificity of Ab accumulation in post-mortem tissue [7, 51] .
One potential way of interpreting results in this study is to consider the effect of Ab accumulation. It is well-known that Ab accumulation causes cellular toxicity and eventual cellular degeneration; however, these effects require a long period to become apparent in humans (namely, apparent in AD patients) [26] . Therefore, it seems unreasonable to conclude that Ab accumulation is irrelevant to the fall of synaptic proteins and/or to the increase in glial cells from results of this study using non-demented individuals. Analysis of AD samples would be necessary to test such a possibility.
In summary, we show that two independent (i.e., synapse-mediated and apoE-mediated) processes might contribute to region-specific Ab accumulation in nondemented individuals. Further development of clinical imaging techniques that can detect individual molecular distributions or a post-mortem approach that can link antemortem state will validate the underlying mechanisms of the regional vulnerability to Ab accumulation.
